• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种在大肠杆菌中以可溶形式生产重组组织蛋白酶V和其他半胱氨酸组织蛋白酶的简单高效方法。

A simple and efficient protocol for the production of recombinant cathepsin V and other cysteine cathepsins in soluble form in Escherichia coli.

作者信息

Novinec Marko, Pavšič Miha, Lenarčič Brigita

机构信息

Department of Chemistry and Biochemistry, Faculty of Chemistry and Chemical Technology, University of Ljubljana, SI-1000 Ljubljana, Slovenia.

出版信息

Protein Expr Purif. 2012 Mar;82(1):1-5. doi: 10.1016/j.pep.2011.11.002. Epub 2011 Nov 11.

DOI:10.1016/j.pep.2011.11.002
PMID:22100277
Abstract

Cysteine cathepsins are major players in numerous physiologic and pathologic processes and important drug targets. Several different expression systems have been developed for the production of these enzymes. Here we describe a novel, simple and efficient protocol for the production of recombinant cathepsin V and other cysteine cathepsins. Recombinant procathepsin V was expressed in soluble form in the cytoplasm of Escherichia coli and purified in one step by immobilized nickel ion-affinity chromatography, yielding approximately 0.7 mg procathepsin V per liter bacterial culture. The recombinant proenzyme was then autocatalytically activated in vitro by incubation at pH 4.0 and 30 °C. The yield of proenzyme conversion was over 95% and the mature enzyme exhibited potent activity towards several commonly used synthetic substrates. The same protocol also proved successful in the production of several other cysteine procathepsins, such as cathepsin B, demonstrating that this procedure is widely applicable for the production of recombinant papain-like cysteine peptidases.

摘要

半胱氨酸组织蛋白酶是众多生理和病理过程中的主要参与者,也是重要的药物靶点。已经开发了几种不同的表达系统来生产这些酶。在此,我们描述了一种生产重组组织蛋白酶V和其他半胱氨酸组织蛋白酶的新颖、简单且高效的方法。重组组织蛋白酶原V以可溶形式在大肠杆菌细胞质中表达,并通过固定化镍离子亲和层析一步纯化,每升细菌培养物可产生约0.7毫克组织蛋白酶原V。然后,通过在pH 4.0和30°C下孵育,使重组酶原在体外自动催化激活。酶原转化率超过95%,成熟酶对几种常用的合成底物表现出强大的活性。同样的方法在生产其他几种半胱氨酸组织蛋白酶原(如组织蛋白酶B)时也被证明是成功的,这表明该方法广泛适用于生产重组木瓜蛋白酶样半胱氨酸肽酶。

相似文献

1
A simple and efficient protocol for the production of recombinant cathepsin V and other cysteine cathepsins in soluble form in Escherichia coli.一种在大肠杆菌中以可溶形式生产重组组织蛋白酶V和其他半胱氨酸组织蛋白酶的简单高效方法。
Protein Expr Purif. 2012 Mar;82(1):1-5. doi: 10.1016/j.pep.2011.11.002. Epub 2011 Nov 11.
2
Cloning and expression of the cathepsin F-like cysteine protease gene in Escherichia coli and its characterization.组织蛋白酶F样半胱氨酸蛋白酶基因在大肠杆菌中的克隆、表达及其特性分析
J Microbiol. 2007 Apr;45(2):158-67.
3
Activity and deletion analysis of recombinant human cathepsin L expressed in Escherichia coli.在大肠杆菌中表达的重组人组织蛋白酶L的活性及缺失分析。
J Biol Chem. 1989 Dec 5;264(34):20487-95.
4
Cloning, expression and characterisation of murine procathepsin E.小鼠组织蛋白酶原E的克隆、表达及特性分析
FEBS Lett. 1997 May 12;408(1):62-6. doi: 10.1016/s0014-5793(97)00388-8.
5
Preparation of active recombinant cathepsin K expressed in bacteria as inclusion body.以包涵体形式在细菌中表达的活性重组组织蛋白酶K的制备。
Protein Expr Purif. 2002 Aug;25(3):541-6. doi: 10.1016/s1046-5928(02)00033-5.
6
Crystal structure of human procathepsin X: a cysteine protease with the proregion covalently linked to the active site cysteine.人组织蛋白酶X的晶体结构:一种前区与活性位点半胱氨酸共价连接的半胱氨酸蛋白酶。
J Mol Biol. 2000 Jan 28;295(4):939-51. doi: 10.1006/jmbi.1999.3410.
7
Recombinant human cathepsin H lacking the mini chain is an endopeptidase.缺乏小链的重组人组织蛋白酶H是一种内肽酶。
Biochemistry. 2003 Nov 25;42(46):13522-8. doi: 10.1021/bi035355k.
8
Purification and characterization of recombinant human cathepsin E expressed in human kidney cell line 293.在人肾细胞系293中表达的重组人组织蛋白酶E的纯化及特性鉴定
Protein Expr Purif. 2004 Sep;37(1):53-60. doi: 10.1016/j.pep.2004.05.013.
9
Expression in Escherichia coli, refolding, and purification of human procathepsin K, an osteoclast-specific protease.
Protein Expr Purif. 1999 Mar;15(2):213-20. doi: 10.1006/prep.1998.1013.
10
The propeptide of cruzipain--a potent selective inhibitor of the trypanosomal enzymes cruzipain and brucipain, and of the human enzyme cathepsin F.克氏锥虫蛋白酶原——一种对锥虫酶克氏锥虫蛋白酶和布鲁氏锥虫蛋白酶以及人类组织蛋白酶F具有强大选择性抑制作用的前肽。
FEBS J. 2007 Mar;274(5):1224-34. doi: 10.1111/j.1742-4658.2007.05666.x.

引用本文的文献

1
Improved recombinant expression of soluble cathepsin B and L in Escherichia coli.提高可溶性组织蛋白酶B和L在大肠杆菌中的重组表达。
Appl Microbiol Biotechnol. 2024 Dec 16;108(1):536. doi: 10.1007/s00253-024-13374-1.
2
Calpeptin is a potent cathepsin inhibitor and drug candidate for SARS-CoV-2 infections.卡培他滨是一种有效的组织蛋白酶抑制剂,也是用于治疗 SARS-CoV-2 感染的候选药物。
Commun Biol. 2023 Oct 18;6(1):1058. doi: 10.1038/s42003-023-05317-9.
3
AlphaFold-Multimer predicts cross-kingdom interactions at the plant-pathogen interface.
AlphaFold-Multimer 预测了植物-病原体界面的跨物种相互作用。
Nat Commun. 2023 Sep 27;14(1):6040. doi: 10.1038/s41467-023-41721-9.
4
Cathepsin K in Pathological Conditions and New Therapeutic and Diagnostic Perspectives.组织蛋白酶 K 在病理条件下的作用及新的治疗和诊断前景。
Int J Mol Sci. 2022 Nov 9;23(22):13762. doi: 10.3390/ijms232213762.
5
Zinc pyrithione is a potent inhibitor of PL and cathepsin L enzymes with inhibition of SARS-CoV-2 entry and replication.吡啶硫酮锌是一种有效的 PL 和组织蛋白酶 L 酶抑制剂,可抑制 SARS-CoV-2 的进入和复制。
J Enzyme Inhib Med Chem. 2022 Dec;37(1):2158-2168. doi: 10.1080/14756366.2022.2108417.
6
Inhibition of Human Cathepsins B and L by Caffeic Acid and Its Derivatives.咖啡酸及其衍生物对人组织蛋白酶 B 和 L 的抑制作用。
Biomolecules. 2020 Dec 29;11(1):31. doi: 10.3390/biom11010031.
7
Rational Design of Recombinant Papain-Like Cysteine Protease: Optimal Domain Structure and Expression Conditions for Wheat-Derived Enzyme Triticain-α.重组木瓜蛋白酶样半胱氨酸蛋白酶的合理设计:小麦源酶Triticain-α的最佳结构域结构和表达条件
Int J Mol Sci. 2017 Jun 29;18(7):1395. doi: 10.3390/ijms18071395.
8
Approaches for the generation of active papain-like cysteine proteases from inclusion bodies of Escherichia coli.从大肠杆菌包涵体中生成活性木瓜蛋白酶样半胱氨酸蛋白酶的方法。
World J Microbiol Biotechnol. 2015 May;31(5):681-90. doi: 10.1007/s11274-015-1804-7. Epub 2015 Mar 20.
9
Probing the activity modification space of the cysteine peptidase cathepsin K with novel allosteric modifiers.用新型变构调节剂探究半胱氨酸蛋白酶组织蛋白酶K的活性修饰空间。
PLoS One. 2014 Sep 3;9(9):e106642. doi: 10.1371/journal.pone.0106642. eCollection 2014.